Samuel Lehrer

The introduction of laser technology continues to pave way for experimentation with new procedures. The precision of the laser allows surgeons to make incisions and cuts with a correctness would be otherwise impossible using traditional means. Lasers also offer effectiveness, efficiency and a quicker recovery time for patients. Samuel Lehrer and his companies, MedLaser Depot, Off Lease Laser, the Laser Repair Depot and the Laser Outlet, are key players in the laser medicine industry.

These companies are laser distributors that specialize in refurbished equipment. The company offers international and domestic business to a wide variety of clients, from individuals to businesses. Clients can call the company for consultation services as well as repairs for their cosmetic laser equipment. They are recognized for their prompt, affordable service and are a top seller in the industry. All technicians are properly trained and knowledgeable in the process of repairing and re-certifying equipment. MedLaser Depot, Laser Repair Depot, the Laser Outlet and Off Lease Laser review all equipment to ensure it meets company standards. Every piece of refurbished equipment meets certification standards and is extensively tested for safety and functionality.

“It is amazing to think that all of the amazing advantages of procedures like these are possible only because of the widespread accessibility of laser technology,” said Samuel Lehrer, CEO of Laser Repair Depot. “That’s why it is so important to keep lasers affordable to medical providers all over the country.”

Sam Lehrer’s assistance in the medical industry is not limited to the convenience his companies provide. He is also recognized as the largest sponsor of cystic fibrosis. Sam Lehrer with the support of his companies assisted in organizing a family fishing tournament in Fort Lauderdale, Florida that raised more than $20,000 to fund medical research for the cause. In the coming tournaments, he is making it a goal to reach and exceed $60,000 in fundraising for research in Cystic Fibrosis and other life-threatening diseases.